Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clarissa Baldotto
Institution:
D’Or Institute for Research and Education
Observed institutions:
Faculdade de Medicina de São José do Rio Preto,
AC Camargo Hospital,
D’Or Institute for Research and Education
ORCID:
0000-0001-9539-3094
Observed ORCID:
0000-0001-9539-3094
OpenAlex ID:
A5133839765
Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer
2025
·
Jianxing He
, Masahiro Tsuboi
, et al.
·
Journal of Clinical Oncology
·
145
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
2026
·
Hidetoshi Hayashi
, Byoung Chul Cho
, et al.
·
Journal of Thoracic Oncology
·
8
Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non–Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT)
2026
·
Eldsamira Mascarenhas
, Clarissa Baldotto
, et al.
·
JCO Global Oncology
·
1
PDF
A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib
2026
·
Filippo de Marinis
, Tae Min Kim
, et al.
·
Figshare
A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib
2026
·
Filippo de Marinis
, Tae Min Kim
, et al.
·
Future Oncology
Impact of liquid biopsy training on real-world testing practices for advanced NSCLC across Latin America: The OMEGA (LACOG 0424/GBOT) survey.
2026
·
Leonardo Gil Santana
, Erick F. Saldanha
, et al.
·
Journal of Clinical Oncology
Real-world patterns and temporal trends of first-line immunotherapy use in metastatic NSCLC in Brazil according to PD-L1 expression.
2026
·
Sofia Vidaurre Mendes
, Eldsamira Mascarenhas
, et al.
·
Journal of Clinical Oncology
CancerTrialsBR: An open-access, collaborative platform to improve visibility and access to cancer clinical trials in Brazil.
2026
·
Felippe Lazar Neto
, Simone Romariz
, et al.
·
Journal of Clinical Oncology
Abstract LB474: Impact of first-line (1L) amivantamab-lazertinib vs osimertinib on second-line (2L) progression-free survival (PFS)
2026
·
David R. Spigel
, Danny Nguyen
, et al.
·
Cancer Research
Real World Data on Locally Advanced Non-small Cell Lung Cancer (nsclc) Patients in Brazil and the Impact of Health Insurance Type on Clinical Outcomes (relance Study / Lacog 0118)
2022
·
Vladmir Cláudio Cordeiro de Lima
, Gilberto de Castro
, et al.
·
Brazilian Journal of Oncology
Practicing Personalized Medicine in Non-small-cell-lung-cancer (nsclc) in Brazil: Medical Oncologists Challenges and Perspectives
2021
·
Pedro Henrique Silva Martinez
, Pedro Henrique Cruz Farina
, et al.
·
Brazilian Journal of Oncology
Show more works
View as search
Works count:
11
Citation count:
160
H-index:
2
I10-index:
1
Year
Topic
Type